Status:
UNKNOWN
Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section
Lead Sponsor:
Ain Shams Maternity Hospital
Conditions:
Bleeding
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss during and after elective LSCS will be investigated.
Detailed Description
To state the effectiveness clinically and laboratory and safety of tranexamic acid in reducing blood loss during and after the elective lower segment cesarean section.
Eligibility Criteria
Inclusion
- \- Women undergoing caesarean delivery for various elective indications.
- Full term primiparas / multiparas.
- Singleton pregnancy being delivered by LSCS.
Exclusion
- \- Medical problems involving the heart, liver, kidney and brain .
- Blood disorders.
- Allergy to tranexamic acid.
- History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia, uterine anomalies and pathology.
- Multiple pregnancy, macrosomia.
- Polyhydromnios .
- Patients requiring blood transfusion due to anemia
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2015
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02279186
Start Date
September 1 2014
End Date
September 1 2015
Last Update
November 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams Maternity Hospital
Cairo, Egypt, 02